Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults

Psychoneuroendocrinology

Volumn 42, Issue , 2014, Pages 118-123

  Lin, Feng ^a,b   Suhr, Julie ^c   Diebold, Stephanie ^d   Heffner, Kathi L ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c OHIO UNIVERSITY   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Depressive symptoms; IGF 1; Learning; Memory

Indexed keywords

SOMATOMEDIN C;

ADULT; AMNESIA; ARTICLE; AUDITORY VERBAL LEARNING TEST; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECALL; RECOGNITION; SYMPTOM ASSESSMENT;

DEPRESSIVE SYMPTOMS; IGF-1; LEARNING; MEMORY;

AGED; AGED, 80 AND OVER; COGNITION; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MEMORY DISORDERS; MIDDLE AGED;

EID: 84895893782     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.01.006     Document Type: Article

References (19)

1. Aleman A., Torres-Aleman I. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog. Neurobiol. 2009, 89:256-265.
2. Cassilhas R.C., Antunes H.K., Tufik S., de Mello M.T. Mood, anxiety, and serum IGF-1 in elderly men given 24 weeks of high resistance exercise. Percept. Mot. Skills 2010, 110:265-276.
3. Deak F., Sonntag W.E. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J. Gerontol. A: Biol. Sci. Med. Sci. 2012, 67:611-625.
4. Dere E., Pause B.M., Pietrowsky R. Emotion and episodic memory in neuropsychiatric disorders. Behav. Brain Res. 2010, 215:162-171.
5. Deuschle M., Blum W.F., Strasburger C.J., Schweiger U., Weber B., Korner A., Standhardt H., Gotthardt U., Schmider J., Pflaum C.D., Heuser I. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients. Psychoneuroendocrinology 1997, 22:493-503.
6. Gatti R., De Palo E.F., Antonelli G., Spinella P. IGF-I/IGFBP system: metabolism outline and physical exercise. J. Endocrinol. Invest. 2012, 35:699-707.
7. Heffner K.L., Ng H.M., Suhr J.A., France C.R., Marshall G.D., Pigeon W.R., Moynihan J.A. Sleep disturbance and older adults' inflammatory responses to acute stress. Am. J. Geriatr. Psychiatry 2012, 20:744-752.
8. Mitchell K.J., Johnson M.K. Source monitoring 15 years later: what have we learned from fMRI about the neural mechanisms of source memory?. Psychol. Bull. 2009, 135:638-677.
9. Paslakis G., Blum W.F., Deuschle M. Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression. Med. Hypotheses 2012, 79:222-225.
10. Portella M.J., Marcos T., Rami L., Navarro V., Gasto C., Salamero M. Residual cognitive impairment in late-life depression after a 12-month period follow-up. Int. J. Geriatr. Psychiatry 2003, 18:571-576.
11. Reinhardt R.R., Bondy C.A. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994, 135:1753-1761.
12. Sonntag W.E., Deak F., Ashpole N., Toth P., Csiszar A., Freeman W., Ungvari Z. Insulin-like growth factor-1 in CNS and cerebrovascular aging. Front. Aging Neurosci. 2013, 5:27.
13. Steenland K., Karnes C., Seals R., Carnevale C., Hermida A., Levey A. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. J. Alzheimers Dis. 2012, 31:265-275.
14. Storbeck J., Clore G.L. Affect influences false memories at encoding: evidence from recognition data. Emotion 2011, 11:981-989.
15. Talbot K., Wang H.Y., Kazi H., Han L.Y., Bakshi K.P., Stucky A., Fuino R.L., Kawaguchi K.R., Samoyedny A.J., Wilson R.S., Arvanitakis Z., Schneider J.A., Wolf B.A., Bennett D.A., Trojanowski J.Q., Arnold S.E. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 2012, 122:1316-1338.
16. Thompson S., Herrmann N., Rapoport M.J., Lanctot K.L. Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis. Can. J. Psychiatry 2007, 52:248-255.
17. Ungvari Z., Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J. Gerontol. A: Biol. Sci. Med. Sci. 2012, 67:599-610.
18. van Dam P.S., Aleman A. Insulin-like growth factor-I, cognition and brain aging. Eur. J. Pharmacol. 2004, 490:87-95.
19. Yan H., Mitschelen M., Bixler G.V., Brucklacher R.M., Farley J.A., Han S., Freeman W.M., Sonntag W.E. Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J. Endocrinol. 2011, 211:27-37.